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ABSTRACT
Objectives: Implementation studies are often poorly
reported and indexed, reducing their potential to
inform the provision of healthcare services. The
Standards for Reporting Implementation Studies
(StaRI) initiative aims to develop guidelines for
transparent and accurate reporting of implementation
studies.
Methods: An international working group developed
the StaRI guideline informed by a systematic literature
review and e-Delphi prioritisation exercise. Following a
face-to-face meeting, the checklist was developed
iteratively by email discussion and critical review by
international experts.
Results: The 27 items of the checklist are applicable
to the broad range of study designs employed in
implementation science. A key concept is the dual
strands, represented as 2 columns in the checklist,
describing, on the one hand, the implementation
strategy and, on the other, the clinical, healthcare or
public health intervention being implemented. This
explanation and elaboration document details each of
the items, explains the rationale and provides examples
of good reporting practice.
Conclusions: Previously published reporting
statements have been instrumental in improving
reporting standards; adoption by journals and authors
may achieve a similar improvement in the reporting of
implementation strategies that will facilitate translation
of effective interventions into routine practice.
Implementation science bridges the gap
between developing and evaluating effective
interventions and implementation in routine
practice to improve patient and population
health.1 Implementation studies are however
often poorly reported and indexed,2 3 reducing
their potential to inform the provision of
healthcare services and improve health out-
comes.4 The Standards for Reporting
Implementation Studies (StaRI) initiative aimed
to develop standards for transparent and accur-
ate reporting of implementation studies. The
StaRI statement describing the scope and
conceptual underpinning is published in the
BMJ;5 this elaboration document provides
detailed explanation of the individual items.
METHODS
Following established guidelines,6 7 we con-
vened a consensus working group in London
at which 15 international multidisciplinary dele-
gates considered candidate items identiﬁed by
a previous systematic literature review and an
international e-Delphi prioritisation exercise,8
in the context of other published reporting
standards and the panel’s expertise in imple-
mentation science. The resultant checklist was
subsequently developed iteratively by email dis-
cussion, and feedback on the penultimate draft
guideline sought from colleagues working in
implementation science.
Strengths and limitations of this study
▪ We followed recommended methodology for
developing health research reporting guidelines,
including a literature review, an e-Delphi exercise,
an international face-to-face consensus meeting
and inviting expert feedback on draft versions of
the Standards for Reporting Implementation
Studies (StaRI) checklist.
▪ Implementation science is a broad field, and
although the e-Delphi, working group and expert
feedback enabled input from experts from a
range of implementation science-related disci-
plines, we may have missed some perspectives.
▪ Distance and financial constraints limited the
geographical spread of representatives at the
face-to-face consensus working group, but we
invited feedback on the penultimate draft from
experts from across the world.
▪ Although our initial feedback suggests general
agreement with the underlying concepts, the
StaRI guidelines will need to be refined in the
light of authors’ and editors’ practical experience
of using the checklist.
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Scope of the StaRI reporting standards
Implementation research is the scientiﬁc study of methods
to promote the systematic uptake of evidence-based inter-
ventions into practice and policy and hence improve
health.9–11 The discipline encompasses a broad range of
methodologies applicable to improving the dissemination
and implementation of clinical, healthcare, global health
and public health interventions.12–14 The StaRI checklist
focuses primarily on standards for reporting studies that
evaluate implementation strategies developed to enhance
the adoption, implementation and sustainability of inter-
ventions,15 but some items may be applicable to other
study designs used in implementation science.
The StaRI reporting guidelines
Unlike most reporting guidelines that apply to a speciﬁc
research methodology, StaRI is applicable to the broad
range of study designs employed in implementation
science. Authors are referred to other reporting stan-
dards for advice on reporting speciﬁc methodological
features. In an evolving ﬁeld, in which there is a range
of study designs, terminology is neither static nor used
consistently.16 For clarity, we have adopted speciﬁc terms
in this paper; table 1 deﬁnes these terms and lists some
of the alternative or related terminology.
Underpinning the StaRI reporting standards are the
dual strands of describing, on the one hand, the imple-
mentation strategy and, on the other, the clinical, health-
care or public health intervention being implemented.17
These strands are represented as two columns in the
checklist (see table 2). The primary focus of implemen-
tation science is the implementation strategy15 (column
1) and the expectation is that this will always be fully
completed. The impact of the intervention on the target
population should always be considered (column 2) and
either health outcomes reported or robust evidence
cited to support a known beneﬁcial effect of the inter-
vention on the health of individuals or populations.
While all items are worthy of consideration, not all items
will be applicable to or feasible in every study; a fully
completed StaRI checklist may thus include a number of
‘not applicable’ items. For example, studies simultan-
eously testing a clinical intervention and an implementa-
tion strategy (Hybrid type 2 designs) would need to fully
address both strands, whereas studies testing a clinical
intervention while gathering information on its potential
for implementation (Hybrid type 1) or testing an imple-
mentation strategy while observing the clinical outcomes
(Hybrid Type 3) would focus primarily on items in the
clinical intervention or implementation strategy
columns, respectively.14
Item 1. Title
Identification as an implementation study, and description of the methodology in the title and/or keywords
Examples - Titles
Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV
controlled implementation study.18
Adaptive Implementation of Effective Programs Trial (ADEPT): cluster randomized SMART trial comparing a standard versus
enhanced implementation strategy to improve outcomes of a mood disorders program.19
Explanation
In addition to specifying the study design used (eg, cluster RCT, controlled before-and-after study, mixed-methods, economic
evaluation, etc), it is important to identify the work explicitly as an implementation study, so that indexers, readers and
systematic reviewers can easily identify relevant studies. The study design and ‘implementation study’ should both be
included as key words and in the abstract.
Item 2. Abstract
Identification as an implementation study, including a description of the implementation strategy to be tested, the
evidence-based intervention being implemented, and defining the key implementation and health outcomes.
Examples - Abstracts
Background: Attendance for routine asthma reviews is poor. A recent randomised controlled trial found that telephone
consultations can cost-effectively and safely enhance asthma review rates…
Design of study: Phase IV controlled before-and-after implementation study.
Setting: A large UK general practice.
Method: Using existing administrative groups, all patients with active asthma (n = 1809) received one of three asthma review
services: structured recall with a telephone-option for reviews versus structured recall with face-to-face-only reviews, or
usual-care (to assess secular trends). Main outcome measures were: proportion of patients with active asthma reviewed
within the previous 15 months… mode of review, enablement, morbidity, and costs to the practice.18
Background: Good quality evidence has been summarised into guideline recommendations to show that peri-operative fasting
times could be considerably shorter than patients currently experience. The objective of this trial was to evaluate the
effectiveness of three strategies for the implementation of recommendations about peri-operative fasting.
ELABORATION ON INDIVIDUAL CHECKLIST ITEMS
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Methods: A pragmatic cluster randomised trial underpinned by the PARIHS framework was conducted during 2006 to 2009
with a national sample of UK hospitals using time series with mixed methods process evaluation and cost analysis. Hospitals
were randomised to one of three interventions: standard dissemination (SD) of a guideline package, SD plus a web-based
resource championed by an opinion leader, and SD plus plan-do-study-act (PDSA). The primary outcome was duration of
fluid fast prior to induction of anaesthesia. Secondary outcomes included duration of food fast, patients’ experiences, and
stakeholders’ experiences of implementation, including influences. ANOVA was used to test differences over time and
interventions.
Results: Nineteen acute NHS hospitals participated. Across timepoints, 3,505 duration of fasting observations were recorded.
No significant effect of the interventions was observed for either fluid or food fasting times. The effect size was 0.33 for the
web-based intervention compared to SD alone for the change in fluid fasting and was 0.12 for PDSA compared to SD alone.
The process evaluation showed different types of impact, including changes to practices, policies, and attitudes. A rich picture
of the implementation challenges emerged, including interprofessional tensions and a lack of clarity for decision-making
authority and responsibility.20
Explanation
For clarity of indexing and identification, the abstract should state clearly the study design and identify the work as an
implementation study. In line with the concept of dual strands that underpins the StaRI checklist, the implementation strategy
and the evidence-based intervention being implemented should be described. Other important information that should be
included are the context, implementation outcomes, resource use and, if appropriate, health intervention outcomes.
Item 3. Introduction (Identify the problem)
Description of the problem, challenge or deficiency in healthcare or public health that the intervention being implemented aims
to address.
Examples - Identify the problem
In the U.S., a substantial percentage of morbidity and mortality (about 37%) is related to four unhealthy behaviors: tobacco
use, unhealthy diet, physical inactivity, and risky alcohol use… Primary care clinicians have many opportunities to assist their
patients in modifying unhealthy behaviors; however, they are hampered by inadequate time, training, and delivery systems.21
Despite significant morbidity, attendance for routine asthma reviews is poor… Telephone consultations offer alternative
access to routine asthma reviews, although a recent UK ruling decreed that the evidence base for this approach in asthma
care was ‘insufficient’.18
Explanation
Identifying and characterising the problem or deficiency that the intervention was designed to address may require data on, for
example, the epidemiology of the condition, its impact on individuals or healthcare resources and evidence of a ‘research to
practice’ gap (eg, actual performance rates). Characterising the challenge for implementation requires a description of the
context in which the intervention will be implemented. This should include a summary of the key factors that might affect
successful implementation in terms of the wider context (eg, governmental policies, major philosophical paradigms influencing
decision makers, availability of resources) as well as barriers and enablers within the organisation and at individual
professional level.9
Item 4. Introduction (Rationale: implementation strategy and intervention)
The scientific background and rationale for the implementation
strategy (including any underpinning theory/framework/model,
how it is expected to achieve its effects and any pilot work).
The scientific background and rationale for the intervention
being implemented (including evidence about its
effectiveness and how it is expected to achieve its effects).
Examples
Rationale for the implementation strategy Rationale for the intervention
Facilitated rapid-cycle quality-improvement techniques
(plan-do-study-act cycles [PDSA]) and learning collaboratives
are effective in primary care settings, and the two strategies
ought to be complementary.21
… brief interventions delivered in primary care office
settings have affected smoking cessation and alcohol
consumption. Although less evidence supports brief
interventions for improving diet or increasing exercise,
there are reasons for optimism.21
The Health Decision Model, which combines decision analysis,
behavioral decision theory, and health beliefs, is useful to
identify patient characteristics related to treatment adherence
and subsequent blood pressure control… Successful
implementation generally requires a comprehensive approach,
in which barriers and facilitators to change in a specific setting
are targeted.22
If not properly controlled, elevated blood pressure (BP) can
lead to serious patient morbidity and mortality…
Inconsistent patient adherence to the prescribed treatment
regimen is known to contribute to poor rates of BP control
and improving medication adherence has been shown to
be effective in improving BP.22
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Explanation
Authors of implementation studies need to explain the rationale for the choice of implementation strategy and for the validity of
the intervention being implemented:
▪ The implementation strategy and underpinning ‘logic pathway’ will be described in detail in the Methods section (see item
12 for description and table 1 for definition and alternative terminology), but it is likely to be appropriate in the introduction
to identify the approach used with supporting evidence for the choice of implementation theory/model/framework adopted
(see first example: plan–do–study–act cycles21) and/or any pilot work or examples from other clinical areas or contexts. It
will be important to show how the implementation strategy has been adapted to fit the context.
▪ The expectation is that there will be (ideally robust) evidence for the intervention (see second example: improving
adherence improves BP control which reduces morbidity22). It is important that the strength of evidence is made explicit at
the outset,23 especially as sometimes there is pressure to implement an intervention before the evidence base is fully
developed (eg, for political imperatives). This will allow a judgement as to whether it is reasonable to assume that effective
implementation will have health benefits or whether it is necessary to also assess health outcomes. Effective
implementation of some interventions may have such incontrovertible evidence of benefit (eg, reducing smoking
prevalence) that a health outcome may be unnecessary. Even when evidence is strong, the possibility that the impact of an
intervention may be attenuated when it is implemented in routine practice needs to be considered.
It is recommended that reporting the methods, outcomes and conclusions related to the implementation strategy precedes the
corresponding reporting of the health outcomes of the intervention (because the key question in an implementation study is
about the impact of the implementation strategy). However, authors may wish to reverse this in the introduction and establish
that the intervention is effective before explaining the approach they took to implementing it. The use of hybrid study designs,
which combine features of clinical effectiveness and implementation studies, may affect the relative emphasis that is placed
on the implementation and health intervention aspects of trials.14
Item 5. Aims and objectives
The aims of the study, differentiating between implementation objectives and any intervention objectives.
Example - Aim
The aim of our study is to evaluate the process and effectiveness of supported self-management (SMS) implemented as an
integral part of the care for patients with type 2 diabetes mellitus provided by practice nurses. We will simultaneously address
the following research questions:
1. What is the uptake of the SMS programme by the practice nurses, and what barriers hamper the implementation of SMS
in routine primary care?
2. What is the effectiveness of SMS in terms of daily functioning, emotional health status, social participation,
self-management behaviour, and health care use by patients with type 2 diabetes?24
Explanation
The aims and objectives should distinguish between the aim(s) of the implementation strategy and the aim(s) of the
evidence-based intervention that is being implemented, possibly using two specific research questions as in the example.24
The aim of the intervention may be implicit if there is already strong evidence to support the health benefits of the intervention
(eg, reducing smoking prevalence).
Item 6. Methods: study design
The design and key features of the evaluation (cross referencing to any appropriate methodology reporting standards) and
any changes to study protocol, with reasons
Examples - Study design
The trial was designed as an implementation study with a before and after analysis.25
Implementation of Perioperative Safety Guidelines is a multicenter study in nine hospitals using an one-way (unidirectional)
cross-over cluster trial design… It is impossible to deliver such a strategy simultaneously to all hospitals because of logistical,
practical, and financial reasons. For that reason, a stepped wedge cluster randomized trial design is chosen.26
Explanation
The study design should be identified and the rationale explained. Any important changes to the study protocol should be
described (or the absence of changes confirmed).
In contrast to most reporting standards, StaRI is applicable to a broad range of study designs, for example, cluster RCTs,
controlled clinical trials, interrupted time series, cohort, case study, before and after studies, as well as mixed methods
quantitative/qualitative assessments.2 A hierarchy of study design has been suggested in the context of studies implementing
asthma self-management.4 Reporting standards exist for many of these designs such as cluster RCTs,27 pragmatic RCTs,28
observational studies,29 including use of routine data,30 non-randomised public health interventions,31 qualitative studies,32 as
well as templates for describing interventions33 and local quality improvement initiatives.34 The StaRI checklist does not,
therefore, include items related to specific design features (eg, randomisation, blinding, intracluster correlation, matching
criteria for cohorts, data saturation). Authors are referred to appropriate methodological guidance on reporting these aspects
of their study (available from http://www.equator-network.org).
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Table 1 Terminology, definitions and resources
Term used in this
paper
Definition
Sources of information
Alternative terminology and similar
concepts
Implementation
strategy
Methods or techniques used to enhance the adoption, implementation and sustainability of a
clinical programme or practice14–16
Implementation approach
Implementation programmes
Implementation process
Implementation intervention
Exemplar resources: Consolidated Framework For Implementation Research (CFIR) http://www.cfirguide.org/imp.html
Dissemination and implementation models http://www.dissemination-implementation.org/index.aspx
Implementation
outcome
Process or quality measures to assess the impact of the implementation strategy, such as
adherence to a new practice, acceptability, feasibility, adaptability, fidelity, costs and returns14 58
End point
Intervention The evidence-based practice, programme, policy, process, or guideline recommendation that is
being implemented (or deimplemented).12 In the context of healthcare, this might be a preventive,
diagnostic or therapeutic clinical practice, delivery system change, or public health activity being
implemented to improve patient’s outcomes, system quality and efficiency, or population health.
Treatment
Evidence-based intervention
Health outcome Patient-level health outcomes for a clinical intervention, such as symptoms or mortality; or
population-level health status or indices of system function for a system/organisational-level
intervention.14
Health status
Client outcome
Logic pathway The manner in which the implementation strategy is hypothesised to operate Logic model
Causal pathway/model
Mechanisms of action/impact
Theory of change
Driver diagrams
Cause-and-effect diagram (Ishikawa, fishbone
diagrams) Donabedian model
Exemplar resource: Logic models: https:/www.wkkf.org/resource-directory/resource/2006/02/wk-kellogg-foundation-logic-model-development-guide
Process evaluation A study that aims to understand the functioning of an intervention, by examining its
implementation, mechanisms of impact and contextual factors. Process evaluation is
complementary to, but not a substitute for, high quality outcomes evaluation61
Process evaluation aims to describe the strategy for change as planned, the strategy as delivered,
the actual exposure of the target population to the activities that are part of the strategy, and the
experiences of the people exposed60
(Formative evaluation) is a rigorous assessment process designed to identify potential and actual
influences on the progress and effectiveness of implementation efforts62
Formative evaluation
Exemplar resource: process evaluation of complex interventions. Available from https://www.ioe.ac.uk/MRC_PHSRN_Process_evaluation_guidance_
final(2).pdf
‘Barriers and
facilitators’
Aspects related to the individual (ie, healthcare practitioner or healthcare recipient) or to the
organisation that ‘determine its degree of readiness to implement, barriers that may impede
implementation, and strengths that can be used in the implementation effort’50
Drivers
Mediators, Moderators
Contextual factors
Enablers
Organisational conditions for change
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Table 2 Standards for Reporting Implementation Studies (StaRI): the StaRI checklist
Report the
following
‘Implementation strategy’ refers to how the intervention was implemented
‘Intervention’ refers to the healthcare or public health intervention that is being implemented
Checklist item
Implementation strategy Intervention
Title 1 Identification as an implementation study, and description of the methodology in the title and/or keywords
Abstract 2 Identification as an implementation study, including a description of the implementation strategy to be tested, the evidence-based intervention being
implemented and defining the key implementation and health outcomes
Introduction 3 Description of the problem, challenge or deficiency in healthcare or public health that the intervention being implemented aims to address
4 The scientific background and rationale for the implementation strategy
(including any underpinning theory/framework/model, how it is expected to
achieve its effects and any pilot work)
The scientific background and rationale for the intervention being
implemented (including evidence about its effectiveness and how it is
expected to achieve its effects)
Aims and
objectives
5 The aims of the study, differentiating between implementation objectives and any intervention objectives
Methods:
description
6 The design and key features of the evaluation (cross-referencing to any appropriate methodology reporting standards), and any changes to study
protocol, with reasons
7 The context in which the intervention was implemented (consider social, economic, policy, healthcare, organisational barriers and facilitators that
might influence implementation elsewhere)
8 The characteristics of the targeted ‘site(s)’ (eg, locations/personnel/
resources, etc) for implementation and any eligibility criteria
The population targeted by the intervention and any eligibility criteria
9 A description of the implementation strategy A description of the intervention
10 Any subgroups recruited for additional research tasks, and/or nested studies are described
Methods:
evaluation
11 Defined prespecified primary and other outcome(s) of the implementation
strategy, and how they were assessed. Document any predetermined
targets
Defined prespecified primary and other outcome(s) of the intervention
(if assessed), and how they were assessed. Document any
predetermined targets
12 Process evaluation objectives and outcomes related to the mechanism(s) through which the strategy is expected to work
13 Methods for resource use, costs, economic outcomes and analysis for the
implementation strategy
Methods for resource use, costs, economic outcomes and analysis for
the intervention
14 Rationale for sample sizes (including sample size calculations, budgetary constraints, practical considerations, data saturation, as appropriate)
15 Methods of analysis (with reasons for that choice)
16 Any a priori subgroup analyses (eg, between different sites in a multicentre study, different clinical or demographic populations), and subgroups
recruited to specific nested research tasks
Continued
6
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Table 2 Continued
Report the
following
‘Implementation strategy’ refers to how the intervention was implemented
‘Intervention’ refers to the healthcare or public health intervention that is being implemented
Checklist item
Implementation strategy Intervention
Results 17 Proportion recruited and characteristics of the recipient population for the
implementation strategy
Proportion recruited and characteristics (if appropriate) of the recipient
population for the intervention
18 Primary and other outcome(s) of the implementation strategy Primary and other outcome(s) of the intervention (if assessed)
19 Process data related to the implementation strategy mapped to the mechanism by which the strategy is expected to work
20 Resource use, costs, economic outcomes and analysis for the
implementation strategy
Resource use, costs, economic outcomes and analysis for the
intervention
21 Representativeness and outcomes of subgroups including those recruited to specific research tasks
22 Fidelity to implementation strategy as planned and adaptation to suit
context and preferences
Fidelity to delivering the core components of intervention (where
measured)
23 Contextual changes (if any) which may have affected outcomes
24 All important harms or unintended effects in each group
Discussion 25 Summary of findings, strengths and limitations, comparisons with other studies, conclusions and implications
26 Discussion of policy, practice and/or research implications of the
implementation strategy (specifically including scalability)
Discussion of policy, practice and/or research implications of the
intervention (specifically including sustainability)
General 27 Include statement(s) on regulatory approvals (including, as appropriate, ethical approval, confidential use of routine data, governance approval), trial/
study registration (availability of protocol), funding and conflicts of interest
Note: A key concept is the dual strands of describing, on the one hand, the implementation strategy and, on the other, the clinical, healthcare or public health intervention that is being
implemented. These strands are represented as two columns in the checklist. The primary focus of implementation science is the implementation strategy (column 1) and the expectation is that
this will always be completed. The evidence about the impact of the intervention on the targeted population should always be considered (column 2) and either health outcomes reported or
robust evidence cited to support a known beneficial effect of the intervention on the health of individuals or populations. While all items are worthy of consideration, not all items will be applicable
to or feasible within every study.
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Item 7. Methods: context
The context in which the intervention was implemented. (Consider social, economic, policy, healthcare, organisational barriers
and facilitators that might influence implementation elsewhere).
Examples - Context
The program occurred in three of 14 community-based networks that are part of the statewide Community Care of North
Carolina (CCNC) program, an outgrowth of a two-decade effort in North Carolina to better manage the care of Medicaid
patients through enhanced patient-centered medical homes. This public-private partnership has five primary components…
developed to mirror the components of the Wagner Chronic Care Model for the organization of primary care. At a statewide
level, CCNC is operated by North Carolina Community Care Networks, Inc. (NCCCN), a non-profit, tax-exempt organization
that facilitates statewide contracting between the 14 CCNC networks and healthcare payers, including Medicaid and
Medicare, and allows the participating regional networks to share information technology and other centralized resources.
NCCCN also serves as a centralized resource for quality improvement, reporting, web-based case management system,
practice support, and provider and member education.22
All Italian citizens are covered by a government health insurance and are registered with a general practitioner. Primary care
for diabetes is provided by general practitioners and diabetes outpatient clinics. Patients can choose one of these two ways of
accessing the healthcare system, according to their preferences, or they can be referred to diabetes outpatient clinics by their
general practitioners. The Italian healthcare system includes more than 700 diabetes outpatient clinics. The SINERGIA model
is based on a process of disease monitoring and management that tends to exclude the intervention of the diabetologist in the
absence of acute problems. Therefore, diabetologists gain time for patients with more severe diabetes, thus enabling them to
provide highly qualified care to those patients.35
Delivering a multifactorial intervention in our local setting is challenging. Data from a neighboring province showed marked
underuse of proven therapies in subjects with diabetes. Furthermore, there is a shortage of physicians, especially in rural
areas, while fee-for-service reimbursement may not favor optimal chronic disease management. Although the local prevalence
of diabetes (currently 5.3%) is increasing, the greatest incidence and prevalence are in northern communities, which have the
least access to specialists.36
Explanation
Successful implementation of evidence into practice is a planned facilitated process involving the interplay between
individuals, evidence and context to promote evidence-informed practice.37 A rich description of the context is critical to
enable readers to assess the external validity of the study,38 and decide how the study context compares to their situation and
if/how the implementation strategy might be transposed, or need adapting.39 Similarly, the social, political and economic
context influences the ‘entrenched practices and other biases’ that hinder evidence-based deimplementation of unproven
practices.40 41
The Consolidated Framework for Implementation Research (CIFR) defines 39 constructs that may guide reporting of these
contextual dimensions (http://www.cfirguide.org/imp.html). The constructs are clustered within five domains:9 42
▪ ‘Characteristics of the intervention being implemented’ including strength of evidence, adaptability, cost
▪ ‘Outer domain’ including alignment with patient needs, peer pressure/competition, external policy, political drivers,
economic climate, incentives, timescales
▪ ‘Inner domain’ including characteristics and culture of the organisation, perceived need for and capacity to change,
leadership and resources
▪ ‘Characteristics of individuals’ including attitude, self-efficacy, role within the organisation
▪ ‘Process’ by which changes are planned and executed within the organisation
Journal word restrictions will dictate how much detail can be included in the text, but authors should highlight all the key
contextual barriers and facilitators that are likely to influence their implementation strategy and outcomes. The examples
above highlight the policy context promoting patient-centred medical homes,22 the role of diabetologists that enabled a shift in
care,35 and the shortage of specialists that challenged implementation.36 Additional information may be provided in an online
supplementary file or a separate publication.
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Item 8. Methods: Targeted sites and populations
The characteristics of the targeted ‘site(s)’ (e.g. locations/
personnel/ resources etc.) for implementation and any
eligibility criteria.
The population targeted by the intervention and any eligibility
criteria.
Examples
Sites and population targeted by the implementation
strategy
Sites and population targeted by the intervention
This study comprises nine hospitals in the Netherlands: two
academic, four tertiary teaching, and three regional hospitals,
with 200 to up to more than 1,300 beds each. …we believe
these hospitals represent the practice of Dutch hospital care.26
The study focuses on patients undergoing elective
abdominal or vascular surgery with a mortality risk ≥ 1%.
These surgeries are selected because of the estimated
higher risk of complications and hospital mortality…26
The study will be implemented in public health facilities in
Central and Eastern provinces in Kenya and in three regions
in Swaziland… The two criteria for selecting intervention
facility selection were: i) good performance in the previous
study and ii) high throughput of family planning clients (≥100/
month).43
All clients entering the facility for MCH [maternal and child
health] services over the five-day period will be asked to
participate…43
Explanation
Recruitment is considered at two levels:
1. The groups/organisations/locations/providers that were targeted as potential ‘sites’ for the implementation. Although there
may be some overlap with the description of the organisational context (item 7), this is a more specific item related to
recruitment strategy including sampling and eligibility criteria. In the second example, the context might describe public
health facilities in Kenya and Swaziland; the extract refers to the study-specific requirements of good performance in
previous studies and high throughput of family planning clients.43 Note that this is a description of targeted sites; a
description of participating sites will be in the results.
2. The population targeted by the intervention being implemented including any eligibility criteria. In a clinical context, this
might be people with a specific condition (such as requiring abdominal or vascular surgery in the first example),26
registered with a participating site, and there may be criteria (such as high risk of mortality26) that define the population for
whom the intervention is appropriate.
Item 9. Methods: Description
A description of the implementation strategy. A description of the intervention
Examples
Description of the implementation strategy Description of the intervention
Implementation planning for this study began with the
construction of multiple stakeholder partnerships within the
VA PC-MHI program…. [and] was informed by the Promoting
Action on Research Implementation in Health Services
(PARiHS) framework….
Based on stakeholder feedback and project-team
experiences, the implementation strategy for this trial was
developed to include three separate but interrelated
interventions—online clinician training, clinician audit and
feedback, and internal and external facilitation… …
emphasis has been placed on understanding stakeholder
perspectives, using formative and process evaluations such
that the implementation interventions could be modified as
needed during the trial.44
The ACCESS intervention is a manualized brief CBT
[Cognitive Behavioural Therapy] protocol that provides a
flexible, patient-centered approach to increase patient
engagement and adherence, while addressing both the
mental and physical health needs of veterans [chronic
obstructive pulmonary disease or heart failure]. ACCESS
consists of six weekly treatment sessions and two brief (10- to
15-minute) telephone “booster” sessions within a four month
time frame. Participants are asked to attend the first session
in person and can participate in subsequent sessions by
telephone or in person.44
Detailed descriptive information about the content and
processes of the ACCESS intervention can be found
elsewhere.45
Sites not initially responding to REP [Replicating Effective
Programs] (defined as <50% patients receiving ≥3 EBP
[evidence-based practice] sessions) will be randomized to
receive additional support from an EF or both EF/IF
[External/Internal Facilitator]. Additionally, sites randomized
to EF and still not responsive will be randomized to continue
with EF alone or to receive EF/IF. The EF provides technical
expertise in adapting [Life Goals] in routine practice, whereas
the on-site IF has direct reporting relationships to site
leadership to support LG use.19
The EBP to be implemented is Life Goals (LG) for patients
with mood disorders across 80 community-based outpatient
clinics… LG is a psychosocial intervention for mood disorders
delivered in six individual or group sessions, which includes
10 components: self-management sessions, values,
collaborative care, self-monitoring, symptom profile, triggers,
cost/benefit analysis of responses, life goals, care
management, and provider decision support. Based on social
cognitive theory, LG encourages active discussions focused
on individuals’ personal goals that are aligned with healthy
behavior change and symptom management strategies.19
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Explanation
Descriptions of implementation strategies and complex interventions are criticised as being inconsistently labelled, poorly
described, rarely justified, not easy to understand15 46 47 and not sufficiently detailed to enable the intervention to be
replicated.48
There needs to be a description of the implementation strategy and the intervention being implemented.
1. Implementation strategies are the ‘bundle’ of techniques used to enhance the adoption, integration into routine practice
and sustainability of a clinical programme or practice.14 The Cochrane Effective Practice and Organisation of Care (EPOC)
Review Group, considers strategies in the categories of professional, financial, organisational and regulatory.49 Others
have identified 73 potential implementation techniques from which relevant components may be selected.50 A framework
such as that described by Proctor et al15 would enable consistent comprehensive reporting:
▪ Actors: The key players (eg, administrators, payers, providers, patients/consumers, advocates) who enact the strategy—
or enable the strategy to be enacted. The investigator’s role should be explicit (eg, a public health strategy over which
they have no control; or an implementation process which they are driving).
▪ Action: The specific activities, steps or processes that constitute the implementation strategy, and how and when these may
interact.
▪ Action target: Strategies may be targeted at specific barriers, enablers, characteristics of the context, processes and
other factors influencing the adoption of the intervention. The personnel, organisation or activity targeted by the
implementation strategy should be described.
▪ Temporality: The steps, sequence of actions and timeframe over which the strategy is to be enacted
▪ Dose: Frequency, duration and intensity of the actions of implementation strategy.
▪ Implementation outcome(s) likely to be affected by the strategy: Outcomes are defined in item 11; but it may be helpful
to signpost these at this stage to ensure that chosen outcomes link explicitly to the implementation strategy and the
proposed mechanism of action.
▪ Theoretical, empirical and/or pragmatic justification for the choice of implementation strategies: These may have been
identified in the introduction (item 4), but reference to theoretical models, mapping determinants of practice to effective
implementation techniques and any pilot work are likely to be appropriate in the methods.
▪ Word counts will restrict the description possible within the text, but authors should consider writing a more detailed
description, for example, as an online supplementary file. Standards for reporting behavioural change interventions
(WIDER) recommend providing access to a manual.51 Some have called for an ‘intervention bank’ in which manuals,
videos, descriptions of implementation strategies and interventions, and other related materials can be stored.52
▪ One practical option is to tabulate this information (see table 3). Alternatively, diagrams or schema may be used to
represent the interacting components of an implementation strategy. Graphical representations53 or ‘cascade diagrams’
have been devised depicting complex interventions,54 and may have potential in describing multilevel implementation
studies. Figure 1 is an exemplar using a timeline.18
2. The intervention that is being implemented also needs to be described, and any developmental work undertaken to adapt
the intervention for implementation cited.55 TIDieR highlights the ‘who, why, what, where, when and how much’ of
describing an intervention.33 Designed to standardise reporting of the development of complex interventions, the CReDECI
checklist56 may aid description of developing and piloting implementation of an intervention.
Different sites participating in the implementation study are likely to adapt further the intervention to suit their specific
context and authors should consider distinguishing between core components of the intervention (to which fidelity is
expected) and elements where adaptation is allowed or even encouraged (see also item 22). A box with details of the
intervention may conveniently distinguish it from the description of the implementation strategy.56
In study designs that include a comparator group, the description of ‘ usual care’ provided to the nonintervention groups
should be sufficiently detailed to enable a reader to judge comparability with their practice and thus the likely impact of the
intervention if implemented in their own setting.
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Table 3 Example of a table describing* an implementation strategy compiled from Kilbourne et al19 description of the implementation of life goals (LG): a clinical
intervention for patients with mood disorders
Name of discrete
strategies
Assess for readiness to adopt LG
intervention. Recruit champions
and train for leadership
Develop and distribute
educational materials, manuals,
toolkits and an implementation
blueprint
Educational meetings, outreach
visits, clinical supervision,
technical assistance, ongoing
consultation
Facilitation (external and
internal) and continuous
implementation advice
Actors Investigators, representatives from
practices and community
Investigators, trainers and LG
providers designated at each site
Trainers and LG providers. Investigators, external and internal
facilitators (EF and IF), LG
providers
Actions Preimplementation meetings with
site representatives for inservice
marketing and dissemination of the
LG programme: overview of LG
evidence, benefits of LG and how to
implement LG. Identify in each site
at least one potential LG providers
with a mental health background and
internal facilitators. Identify
champions. Assess readiness,
barriers and facilitators
Packaging LG protocol and
provider manual (identifying
candidate patients; scripts for
session and follow-up calls;
registry for tracking patients’
progress). Design implementation:
Implementation manual describing
the ‘Replicating Effective
Programs’ (REP) package.
Patients’ workbook (exercises on
behaviour change goals, symptom
assessment, coping strategies…)
Training for LG providers: evidence
behind LG, core elements and
step-by-step walk through LG
components; patient tracking and
monitoring over time and
continuous education via LG
website. Programme assistance
and LG uptake monitoring via LG
website, support by study
programme assistant, biweekly
monitoring form, feedback reports
and newsletters
Initiation and benchmarking: EF
and LG providers identify barriers,
facilitators, and goals. Leveraging:
IF and LG providers identify
priorities, other LG champions, and
added value of LG to site
providers. Coaching: IF, EF and
LG providers phone to develop
rapport and address barriers.
Ongoing marketing: IF, leaders
and LG providers summarise
progress and develop business
plans
Targets Awareness of evidence-based
interventions, engagement and
settings’ readiness to change
Environmental context and
resources, information and access
to interventions
Build knowledge, beliefs, skills and
capabilities: problem solving,
decision-making, interest
Strengths and influences of LG
provider. Measurable objectives
and outcomes in implementing LG
Temporality 1st step: preimplementation 2nd step: REP implementation 3rd step: training and start up 4th step: maintenance/evolution
Dose One informative meeting For continuous use with every
patient, as needed
1-day 8 hour training programme
+continuous assistance and
monitoring
2-day training programme EF and
continuous facilitation activities
Implementation
outcomes
addressed/affected
Barriers, facilitators, specific uptake
goals; organisational factors: ie,
Implementation Leadership Scale,
Implementation Climate Scale,
resources, staff turnover, improved
organisational capacity to implement,
organisational support…
Organisational factors associated
with implementation. Quality of the
supporting materials, packaging
and bundling of the intervention.
Association of available materials’
quality with actual implementation
Providers’ knowledge, skills trust
RE-AIM framework (Reach,
Effectiveness, Adoption,
Implementation and Maintenance)
and LG performance measures of
routine clinical care process: ie,
sessions completed by patient,
percentage completing 6
sessions…
IF, EF and LG provider’s
perceptions, strengths and
opportunities to influence site
activities and overcome barriers.
Adaptation and fidelity monitoring:
ie, number of meetings,
opportunities to leverage LG
uptake. Quality and costs
Theoretical
justification
CDC’s Research to Practice
Framework. Social learning theory
REP framework and implementation strategy for community-based
settings (includes Rogers’ Diffusion of Innovations and Social Learning
Theory)
Adaptive implementation.PARiHS
framework
*Using Proctor et al’s15 framework..
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Figure 1 Example of a timeline describing an implementation strategy (compiled from Pinnock et al18 description of the
implementation of a telephone service for providing asthma reviews). Note: The three-arm implementation study is illustrated in
the centre of this schema with the preceding usual care, randomisation on 1 January 2004, the 15-month intervention and
subsequent roll-out. The context (specifically the introduction of the Quality and Outcome Framework) is shown at the top of the
schema. Below the three-arms of the study are the components of the implementation strategy from set-up and training, ongoing
service provision and maintenance and adoption into routine practice.
Item 10. Methods (subgroups)
Any subgroups recruited for additional research tasks, and/or nested studies are described
Examples - Subgroups
Observations of client–provider interactions: 18 consecutively sampled new family planning/HIV clients and 18 revisit clients
… will be observed. For the postnatal clinic/HIV model … 24 consecutively sampled postpartum women (within 48 hours of
birth, between 1–2 weeks and around 6 weeks postpartum) per study facility (will be recruited)43
Researchers posted the following validated questionnaires, with two reminders, to patients with active asthma in the three
groups at the end of the study year (excluding children aged <12 years, as the questionnaires are not validated for this age
group). The only exclusion criteria were a predominant diagnosis of chronic obstructive pulmonary disease, inability to
complete the questionnaire (eg, because of severe dementia), and patients excluded by their GP for significant medical or
social reasons18
Explanation
Typically in implementation studies, the people targeted by the intervention (eg, patients with a condition registered with a
practice or healthcare organisation; population targeted by a public health initiative) will not have consented to the research.
Some studies may recruit a subgroup of patients to undertake specific research activities. For example, a proportion of
consultations may be observed (see the first example43), a random sample of patients provided with a new service may be
asked to complete questionnaires (see the second example18) or a purposive sample of stakeholders may be recruited for a
qualitative study. The recruitment process for these subgroups should be clearly described.
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Item 11. Methods: Outcomes
Defined pre-specified primary and other outcome(s) of the
implementation strategy, and how they were assessed.
Document any pre-determined targets.
Defined pre-specified primary and other outcome(s) of the
intervention (if assessed), and how they were assessed.
Document any pre-determined targets.
Examples
Outcomes of the implementation strategy
Outcomes of the intervention
The primary outcome measure is guideline adherence
according to the perioperative Patient Safety Indicators as
defined in the national indicator set. This set comprises nine
indicators on the processes and structures of care.26
Secondary (patient) outcomes are in-hospital complications
(with particular attention to postoperative wound infections)
and hospital mortality, as well as length of hospital stay,
unscheduled transfer to the intensive care unit, non-elective
hospital readmission, and unplanned reoperation…26
Implementation outcomes
To assess brief cognitive behavioral therapy (CBT) adoption
and fidelity, as measured by:
a) brief CBT patient engagement (one or more sessions) and
adherence (four or more sessions)
b) Department of Veterans Affairs Primary Care-Mental
Health Integration [VA PC-MHI] clinician brief CBT adherence
and competency ratings as evaluated by expert audio session
reviews.44
Effectiveness outcomes:
To determine whether a brief CBT treatment group as
provided by VA PC-MHI clinicians is superior to a usual-care
control group at post treatment and 8- and 12-month
follow-ups, as measured by:
a) depression and anxiety scores (Patient Health
Questionnaire-9 and Beck Anxiety Inventory)
b) cardiopulmonary disease outcomes (Chronic Respiratory
Questionnaire and Kansas City Cardiomyopathy
Questionnaire).44
Explanation
Figure 2 illustrates the outcomes relevant to implementation science and the StaRI checklist items to which they relate. This
schema borrows from the conceptual models and taxonomy of outcomes described by Proctor et al,16 57 58 but also highlights
the dual strands suggested by the StaRI guideline as underpinning reporting implementation intervention studies. The
outcomes are mapped to the checklist items in which they are described or reported. The outcomes related to the
implementation strategy should be distinguished from outcomes of the intervention:
1. Implementation is the main objective of implementation studies and the primary implementation outcome takes priority.
2. Impact on the primary health outcome is the ultimate aim of implementing the intervention and is therefore important,
though it may not always be measured in an implementation study if the underpinning evidence is sufficiently robust (eg,
bans to restrict exposure to secondhand smoke59).
Figure 2 Summary of outcomes
and the related items in the
Standards for Reporting
Implementation Studies checklist.
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Item 12. Methods: Process evaluation
Process evaluation objectives and outcomes related to the mechanism by which the strategy is expected to work.
Examples
Process evaluation
The outcomes reported in this paper include adoption, implementation, and maintenance from the Reach, Efficacy/
Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Model
Adoption was defined as the percentage of clinicians invited to participate who completed training and implemented
recommended changes.
Implementation [of the intervention] was determined by how well the practices were able, during each 6-month cycle, to fully
incorporate screening and very brief and brief interventions for each behavior into their processes of care, based on
information obtained from the chart audits.
Maintenance was determined by the degree to which practices continued to screen for and provide interventions while
working on the other behaviors.21
In this framework (Hulscher et al.60), attention is paid to features of the target group, features of the implementers, and the
frequency and intensity of intervention activities. Based on this framework we describe the features of the intervention as
performed in detail. The process evaluation will furthermore be based on a questionnaire for the contact persons and a
questionnaire for the health-care providers to measure their experience with the implementation strategy..”26
Explanation
A process evaluation (or formative evaluation) is used to describe the implementation strategy as delivered, and to assess
and explore stakeholder experience of the process of implementation and/or target population experiences of receiving the
intervention.60–62 A process evaluation should be based on an explicit hypothesis (eg, ‘logic pathway’; see table 2 for
alternative terminology) that spans the mechanism of action of the implementation strategy and the mechanism by which
the intervention is expected to improve healthcare. Process data should be related to the hypothesised mechanisms. This
implies that data may need to be collected at multiple time points to capture an evolving process, and the relationship
between the researcher undertaking the process evaluation and the implementation process (eg, whether interim results are
fed back to facilitate adaptation) should be described.61 62 Context (see item 7) may be reported as a component of the
process evaluation.
All outcomes should be clearly defined, including the time point at which they are measured in relation to delivery of the
implementation strategy, to enable interpretation of findings in the context of an evolving process of adoption of the
intervention within organisations and also inform sustainability.
Not all implementation studies will designate a ‘primary outcome’, but this is of sufficient importance in the context of
experimental designs that the terminology has been retained (see table 2 for alternative terms). This also serves to distinguish
implementation outcomes on which a study is powered from the data collected during a process evaluation (see item 12).
Feasibility studies may focus on process rather than primary implementation or health outcomes.
The provenance of data is of particular importance in implementation studies in which participants may not be recruited to the
research. For example, routine data are typically collected for purposes other than research and the intended use (clinical
records, insurance claims, referral patterns, workload monitoring) will influence what and how data are recorded. A description
should be provided of the provenance of the data (data source/purpose and process of collection/data completeness) and
validity of coding.30
It is good practice to define the minimum change that would be considered as representing implementation success (eg, 70%
participation in the intervention) and justify that choice of level.
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For each process evaluation outcome:
▪ Describe the variables, measures, data sources and data collection methods and frequency, and the analytic approaches
employed. Describe who collected data, and the relevance to their role. For example, nurses providing telephone or
face-to-face asthma reviews were asked to record duration of consultations,18 which may have led to inaccuracies either
due to the impracticality of accurate data collection during clinical work and/or bias due to perceived implications for their
workload. The provenance of routine data should be described (see item 12).
▪ Describe methods for assessing fidelity to (and adaptation of) the implementation strategy and to the intervention,
sustainability and learning effects (see also item 22). Iterative changes as a result of ongoing feedback should be
described.
▪ Describe checks employed to assess quality of quantitative and/or qualitative data and analysis. For example, nurses’
assessment of duration of consultations could be checked against appointment schedules.18
Frameworks such as RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance),63 diffusion of
innovation,64 routinisation,65 NPT (Normalisation Process Theory),66 Framework for process evaluation of
cluster-randomised controlled trials (RCT)67 or Stages of Implementation Completion,68 CIFR (Consolidated Framework for
Implementation Research),9 42 Theoretical Domains Framework69 may be useful in developing, analysing and reporting
process evaluations.
Item 13. Methods: Economic evaluation
Methods for resource use, costs, economic outcomes and
analysis for the implementation strategy
Methods for resource use, costs, economic outcomes and
analysis for the intervention
Examples
Economic evaluation of the implementation strategy Economic evaluation of the intervention
Cost analysis of developing and implementing the three
interventions from a national perspective (cost of rolling out a
particular intervention across the NHS)…20
… from the perspective of a single trust (cost of all activity and
resource used by trust employees in implementation)20
Financial data were obtained for the costs of setting up and
running the Improving Access to Psychological Therapies
(IAPT) service for the 2 years of the study, including training,
equipment, facilities and overheads, to provide estimates of
the costs associated with IAPT. Set-up costs were a small
proportion of total costs (less than 10%) and these were
therefore apportioned to this 2-year period rather than the
lifetime of the service.70
The service recorded contact … time in minutes for each
service user and this was used to calculate total contact time
over the 2 years, which was combined with total cost data to
generate an average cost per minute for the IAPT service…
All health and social care services [were] valued using
national unit costs.
A broader perspective of costs was taken by assessing
productivity impact, which we valued using the lost number of
days from work using a human capital approach.70
Explanation
Economic evaluation can inform future implementation and commissioning decisions. Reporting should adhere to existing
guidelines relevant to the study design (eg, the International Society for Pharmacoeconomics and Outcomes Research
(ISPOR) task force guidelines for economic evaluation (including model-based economic evaluation)71 and budget impact
analysis,72 and guidance on social return on investment approaches73). This may require an online supplementary file or a
separate publication.
An additional requirement in reporting implementation research is to relate economic information to the implementation
strategy or the intervention that is being implemented. If possible, reporting should distinguish between the two, with the
practicality of doing so ideally having been considered at design stage. A budget impact analysis estimates changes in the
expenditure of a healthcare system after adoption of a new intervention, and will be of particular interest to those who plan
healthcare budgets.72
Reporting should be transparent and cover the following aspects of the evaluation, as relevant:
▪ Target/eligible population, health system, setting, location and comparator(s).
▪ Perspective (ie, which resources and costs are being considered) using an equivalent approach for intervention and
comparator scenarios, with additional and separate estimates specifically related to the implementation strategy and
intervention.
▪ Time horizon of the evaluation and (if relevant) the discount rate used.
▪ Methods and sources used to derive resource use and cost estimates.
▪ Currency, price date and any conversions.
▪ Outcome/effectiveness measure(s).
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▪ Statistical approaches for analysis of resource use, costs and outcomes, including handling of joint distributions between
these parameters, handling of missing data and any specific considerations, for example, cluster randomisation.74
▪ For models and budget impact analyses, the choice of model/framework, its structure (with graphical representation) and
methods for checking consistency and validity.
▪ For approaches that report composite cost and outcome metrics (eg, incremental cost-effectiveness ratio (ICER) or
probability of cost-effectiveness against a given willingness-to-pay threshold), the outcome should be clearly specified and
justified (particularly if it is not the same as the primary outcome for the related effectiveness evaluation).
▪ Assumptions made, and any planned sensitivity/scenario analyses to explore the impact of such assumptions.
Item 14. Methods: sample size
Rationale for sample sizes (including sample size calculations, budgetary constraints, practical considerations, data saturation,
as appropriate)
Example
Sample size
Assuming an alpha of 0.05 and a beta of 0.90, an improvement in perceived daily functioning (defined as a score less than or
equal to 4 on the Daily Functioning Thermometer, our primary outcome) at T12 occurring in 20% of the patients in the
intervention group versus 5% of those in the control group requires at least a net number of 116 patients per arm (N=232; 5
patients per practice nurse). It will be necessary to take account of a possible dependence between observations on patients
of the same practice nurse (PN). The intra-class correlation coefficient (ICC) is assumed to be 0.04, a median value for
cluster-RCTs in the primary care setting.33 Assuming a 30% loss to follow-up we need to recruit at least 331 patients (8 per
PN). Since participation in the screening procedure will not necessarily mean that patients also give informed consent for the
effect evaluation, 10 consecutive patients for each PN will be invited to participate in the effect evaluation (N=460).24
Explanation
It is important to recruit sufficient participants to be able to address the study’s implementation objectives; the rationale for the
number of sites and/or people recruited to the study needs to be justified. In a trial (eg, a cluster RCT), this will be based on a
sample size calculation using the primary implementation outcome. If health outcomes are also being assessed, consideration
may need to be given to the sample size for the primary health outcome. Design-specific advice on reporting sample size
calculations can be found in relevant reporting standards.27–29 31 75 In studies using qualitative methodology, data saturation
may inform the final sample size. Budgetary constraints and other pragmatic considerations may also be relevant (such as
evaluating an initiative in which size is already determined; in the second example, the sample was ‘all active asthmatics’ in
the practice18).
Item 15. Methods: analysis
Methods of analysis (with reasons for that choice)
Example
Analysis
Numerical data
Analysis was conducted at the cluster level for each Trust… At each time-point, the differences in mean fasting times between
the three intervention groups were compared using analysis of variance (ANOVA). A repeated measure ANOVA across the
time-point means for all trusts, within each intervention group, was conducted. The trend coefficient was not significantly
different to zero: there was no evidence of trend over time pre-or post-intervention therefore data were combined across
timepoints (1 to 4 and 5 to 8) and simple pre- and post-interventions comparisons were conducted using t-tests. The
significance level used for all tests was 5%.
The effect size was calculated for each of the web-based and PDSA interventions compared to standard deviation for change
in fluid fasting time between pre- and post-intervention….
Patient experience questionnaires were analysed in SPSS using descriptive statistics, chi squared tests were used to
compare characteristics pre- and postintervention…. Descriptive and inferential statistics were conducted (on learning
organisational data].
Qualitative data
Audio-recorded individual and focus group interviews were transcribed in full. Data were analysed within data set and
managed in N*DIST 5 (pre-intervention) and NVIVO 7 (post-intervention). A combined inductive and deductive thematic
analysis process was used….
Synthesis
The theoretical framework [developed for this study is based on the Promoting Action on Research Implementation in Health
Services (PARIHS) framework guided the integration of findings across data sets.20
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Explanation
Design-specific advice on reporting analysis can be found in relevant standards.27–29 31 32 75 Consideration needs to be given
to the analysis of primary implementation outcomes and then (if measured) to any health outcomes.
In mixed methods studies, clarity is needed about how different data types (numeric, qualitative) will be managed and
analysed.76 The synthesis of qualitative and quantitative data will be guided by the study’s question(s) or objective(s), and by
its overarching theoretical framework or theory. Reporting should describe and explain implementation processes (eg, delivery
of intervention, facilitators, barriers), contexts (eg, characteristics and influence of) and impacts.
Item 16. Methods: Sub-group analyses
Any a priori sub-group analyses (e.g. between different sites in a multicentre study, different clinical or demographic
populations), and sub-groups recruited to specific nested research tasks
Example - Subgroups
Planned subgroup analyses focus on subgroups of young women. Age is a core issue in gender violence and HIV incidence.
… A further subgroup analysis will examine the effect of the presence of other programmes for HIV prevention, youth
empowerment and reduction in gender violence active in the clusters, with this information collected at the time of the impact
survey77
Explanation
Subgroups should be specified a priori and the method of subgroup analysis clearly specified. Further detail on reporting
analysis of data from subgroups is available in design-specific reporting standards.27–29 31 75
Item 17. Results: Populations
Proportion recruited and characteristics of the recipient
population for the implementation strategy.
Proportion recruited and characteristics (if appropriate) of
the recipient population for the intervention
Examples
Characteristics of recipients of the implementation
strategy
Characteristics of recipients of the intervention
Six practices were classed as rural, seven as urban.
Practice list size ranged from 2,300 to 12,500
(median=7,500, IQR 5,250-10,250). Four urban and three
rural practices were randomly assigned to the intervention
group.78
4,434 adult (age range 18 to 55 years) patients with an
asthma diagnosis made more than 12 months previously
were identified…. A total of 1572 patients, who had received
repeat prescriptions for β2-agonists in the previous 12 months,
were defined as active asthma patients. Of these, 667 (42%)
were considered to have poorly controlled asthma…78
Forty-three practices were randomized: 22 to the intervention
group and 21 to control. Massachusetts practices were a mix
of hospital clinics, independent community health centers, and
private practices. In Michigan, all sites were a part of the Henry
Ford Health System; 1 was hospital-based. …There were no
significant differences in practice characteristics between
intervention and comparison groups.79
The 43 practices identified a total of 13 878 pediatric
patients with asthma who may have been eligible for this
study. …Unexpectedly, at baseline, 53% of the children in
the intervention group had a written asthma management
plan, compared with 37% of the children in the control group
(P0.001). The groups were not different at baseline with
respect to any other measure.79
Explanation
As in cluster RCTs, the populations need to be considered at two levels:
1. Characteristics of the participating sites (eg, demography of a practice/clinic) and the personnel (professional training, staff
skills) who were recipients of the implementation strategy, and control groups (if applicable), and their representativeness
compared with the sites targeted. Note that characteristics of targeted sites are reported in the methods (item 8)
2. Characteristics of recipients of the health intervention. As these individuals will often not have consented to participate in
the research, information is likely to be limited to routine anonymised data.
At each level, reach (the proportion of eligible population who participated and their characteristics) needs to be reported. A
diagram illustrating the flow of targeted/participating sites, professionals and patients may be helpful, potentially adapted from
CONSORT standards for cluster RCTs.27 Published examples of diagrams include a cohort study;80 a controlled
implementation study18 and a before and after study.79
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Item 18. Results: Outcomes
Primary and other outcome(s) of the implementation
strategy.
Primary and other outcome(s) of the Intervention (if
assessed)
Examples
Primary (and other) outcomes of the implementation
strategy
Primary (and other) outcomes of the intervention (if
assessed
The Assessment of Chronic Illness Care measurements,
obtained at the beginning, midpoint and end of the initiatives,
provide evidence of the progressive implementation of the
components of the CCM [Chronic Care Model]. These
results are described using a spider diagram.81
Changes in measures of disease control were more
modest…. Nevertheless, tracking aggregate data by means
of Shewhart p charts showed special cause variation
reflecting improvement in blood pressure and [cholesterol]
control in the late stages of the California Collaborative.
Significant changes were not seen in HbA1c levels.81
There were 4,550 individuals who met inclusion criteria of
which 558 individuals were contacted and received at least a
phone contact… On average, individuals received 4.5 phone
contacts over the 6-month intervention period.22
During the 90 days prior to the first intervention encounter
(index date), 35% of patients were >80% adherent to
hypertension medication. By the period of 90–179 days
following the first encounter, 54% had >80% adherence for
hypertension medication.22
Explanation
We suggest that the primary and other outcomes of the implementation strategy are presented before the impact of the
intervention on primary and other health outcomes (if measured). Authors are referred to design-specific standards for
detailed advice on reporting outcomes.27–31
Item 19. Results: Process evaluation
Process data related to the implementation strategy mapped to the mechanism by which the strategy is expected to work.
Examples
Process data
The Park County Diabetes Project made a number of changes in the delivery of diabetes care and patient education. These
included establishing and maintaining patient registries; nurses conducting mail and telephone outreach to patients in need of
services; mailing personalized patient education materials regarding the ABCs of diabetes; and providing ongoing continuing
education workshops for the health care team. The team redesigned the education curriculum …, provided group education
sessions in community settings, and offered classes regardless of the person’s ability to pay. The diabetes nurse in each
clinic also provided one-on-one diabetes education.
In October 2000, there were 320 patients with diagnosed diabetes receiving care at these clinics, and that number increased
to 392 by February 2003. Among (participating) patients, the proportion receiving an annual foot examination, influenza
immunization, and a pneumococcal immunization increased significantly from baseline to follow-up.82
We identified three sub-themes that clearly distinguished low from high implementation facilities. First, the high quality of working
relationships across service and professional … boundaries was apparent in the high implementation facilities… … The MOVE!
teams at the two high implementation and transition facilities met regularly… … In the low implementation facilities,
communications were poor between staff involved with MOVE! and they did much of their communication through email, if at all.83
Explanation
Process evaluation should be related to the logic pathway, capturing the impact of the implementation strategy on
intermediate/process outcomes on the pathway, as in the second example in which existing good communication facilitated
implementation. It will be important to capture the involvement of the stakeholders in the process of design and
implementation (eg, in the first example where the team redesigned the existing education curriculum). Data of importance to
the main ‘outcome’ are likely to include uptake of and attrition from training, implementation tasks, etc, with explanatory
insights from qualitative evaluation (eg, in the second example). Contextual changes (see item 23) may be reported as a
component of the process evaluation.
If health outcomes are reported, uptake of the intervention by the eligible population will be crucial (as in the first example).
Additional papers may be necessary to report all aspects of process data, and to ensure that some publications directly focus
on issues of importance to specific groups (eg, policymakers, healthcare managers).61
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Item 20. Results: economic evaluation
Resource use, costs, economic outcomes and analysis for the
implementation strategy
Resource use, costs, economic outcomes and analysis for
the intervention
Examples
Health economic outcomes (Implementation strategy) Health economic outcomes (Intervention)
Estimated total up-front investment for this
Coordinated-Transitional Care (C-TraC) pilot was $300 per
person enrolled, which includes all staff, administrative, and
implementation costs.84
… given the observed decrease in re-hospitalizations of
5.8% versus the comparison group, it is estimated that the
C-TraC program avoided 361.6 days in acute care over the
first 16 months, leading to an estimated gross savings of
$1,202,420. After accounting for all program costs, this led
to estimated net savings of $826,337 overall or $663 per
person enrolled over the first 16 months of the program…84
In the base-case analysis, the difference in costs between
intervention and control group was £327, and the difference in
QALYs was 0.027, which generated an ICER point estimate of
£12 111 per QALY gained. The probability of the intervention
being cost effective was 89% at the NICE threshold of £30 000
per QALY.85
Explanation
Reporting of economic results should adhere to existing relevant guidelines.71 72 It should be clear whether the economic
results relate to the implementation strategy, the intervention that is being implemented or both. Reporting should be
transparent and cover the following aspects of the evaluation:
▪ Full description of study parameters, including representation of variation, with separate reporting of resource use and
costs. For models and budget impact analyses, all input parameters should be reported separately.
▪ For composite cost and outcome metrics (eg, an ICER or a probability of cost-effectiveness against a given
willingness-to-pay threshold), individual costs and outcomes should additionally be reported separately.
▪ Separate reporting of any sensitivity analyses.
▪ Provision of budget impact calculators or simulation model programmes may be valued by healthcare decision-makers, and
should be developed following specific guidance.72
Item 21. Results: subgroups
Representativeness and outcomes of subgroups including those recruited to specific research tasks
Example
Representativeness of sub-group
236 (37% of the 629 patients with poorly-controlled asthma) patients consented to provide questionnaire data. One hundred
and six (45%) patients were from control practices, and 130 (55.1%) were from intervention practices. Patients with asthma
who consented to provide baseline questionnaire data were significantly older, more likely to be female and more affluent than
non-consenters. They had significantly fewer β2 agonists inhaler or courses of oral steroids prescribed in the 12 months
pre-study than non-consenters.
One hundred and seventy-seven questionnaires were returned at follow-up out of a possible 236 (75%). Of these, 78/106
(74%) were returned by control practice patients and 99/130 (76%) from intervention practice patients.78
Explanation
Subgroup analyses should be distinguished from outcomes from whole populations (eg, by reporting in a separate table) and
their representativeness compared with the whole eligible population.
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Item 22. Results: Fidelity and adaptation
Fidelity to the implementation strategy as planned and
adaptation to suit context and preferences.
Fidelity to delivering the core components of intervention
(where measured).
Examples
Fidelity and adaptation to the implementation strategy Fidelity and adaptation to the intervention
Although practices were expected to participate fully in the
intervention, actual participation varied considerably.
Attendance at the 3 learning sessions declined progressively
from the first to the third in both states (eg, 34 participants at
the first session in Boston; 24 at the third). On average, only
42% of the practices submitted performance data … with fewer
practices reporting in the later months of the intervention.79
At AD [academic detailing] visit 3… … 46% of the PDAs
[personal digital assistants] indicated that the provider had
discontinued use between visits 2 and 3. …Several providers
reported that, once they adopted electronic medical record
systems, they were less inclined to enter data into the PDA (to
avoid having to interface with 2 different computers).86
[Intervention: adherence to National Cholesterol Education
Program clinical practice guidelines] Appropriate management
of lipid levels decreased slightly (73.4% to 72.3%) in
intervention practices and more markedly (79.7% to 68.9%) in
control practices. The net change in appropriate management
favored the intervention (+9.7%; 95% confidence interval.86
Explanation
Fidelity may be considered at two levels: implementation fidelity and intervention fidelity. Implementation fidelity refers to the
degree of adherence to the described implementation strategy. Intervention fidelity is the degree to which an intervention is
implemented as prescribed in the original protocol. The implementation strategy and the intervention, however, may need to
be adapted if they are to fit within the routines of local practice.86 Adaptation is the degree to which the strategy and
intervention are modified by users during implementation to suit local needs.26 Insufficient fidelity to the ‘active ingredients’ of
an intervention dilutes effectiveness,87 whereas insufficient adaptation stifles tailoring potentially diluting effective
implementation.88 An approach to reporting these apparently contradictory concepts is to define the core components of an
intervention to which fidelity is expected, and those aspects which may be adapted by local sites to aid implementation.59 87
Distinction may be made between an active process of innovative adaptation that facilitates implementation, passive ‘drift’ in
which tasks are allowed to lapse,89 and active subversion which blocks implementation.90
Fidelity should be reported:
1. To the core components of the implementation strategy and any adaptations made by participating sites. A systematic
meta-review of the literature on fidelity measures described four aspects of fidelity required for a comprehensive
assessment (design, training, monitoring of intervention delivery and intervention receipt).91
2. To delivery of the core components of the intervention (or at least considered if not measured) and any adaptations made.
Item 23. Results: context
Contextual changes (if any) which may have affected the outcomes
Example
Contextual changes
The present study coincided with the introduction of the UK General Medical Services contract in January 2004 which rewards
practices who achieve clinical standards, including a target of 70% for the annual review of people with ‘active’ asthma. The
impact of this was seen in the usual-care group which increased the review rate by 14% without a structured recall service.18
Explanation
There should be a description of any important contextual changes (or not) occurring during the study that may have affected
the impact of the implementation strategy—for example, policy incentives, parallel programmes, changes in personnel, media
publicity. The CIFR constructs (see item 7) is a useful framework for describing context,42 and a timeline (see item 9) may be
a convenient way to illustrate potential impact of contextual changes. Contextual changes (see item 19) may be reported as a
component of the process evaluation.
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Item 25: Discussion: summary
Summary of findings, strengths and limitations, comparisons with other studies, conclusions and implications.
Example
Summary findings
The participating practices adopted most elements of the CCM [Chronic Care Model], including development of
inter-professional teams, delegation of provision of care by appropriate team members, implementation of patient
self-management strategies, group visits, proactive patient management—anticipating the needs of patients as opposed to
providing reactive management—and use of an information system to track individual patient measures. In addition, resident
training programs successfully incorporated educational strategies for learning the elements of evidence-based chronic illness
care.81
Explanation
The structure of the discussion will follow the style of the journal, but ideally should include summary of findings, strengths
and limitations, comparisons with other studies, implications (see item 26) and conclusions.96
Item 24. Results: harms
All important harms or unintended effects in each group.
Example
Reporting of harms
[In the context of a computerised decision support to improve prescribing in pregnancy] Two factors contributed to alerts being
based on incorrect patient pregnancy status: either the updated diagnosis had not been coded into administrative data at all or
transfer of the updated coded diagnosis information from hospital administrative data to health plan administrative data was
delayed.92
Explanation
Adverse or unintended consequences of implementation studies are often under-reported.93–95 Any important harms or
unintended effects should be reported, quantified (eg, on health outcomes, organisational efficiency or user satisfaction) and
possible reasons identified (eg, flaws in the intervention, context challenging implementation).91
Item 26. Discussion: Implications
Discussion of policy, practice and/or research implications of
the implementation strategy (specifically including scalability).
Discussion of policy, practice and/or research implications of
the intervention (specifically including sustainability).
Examples
Implications related to the implementation strategy Implications related to the intervention
These initiatives suggest that both the practice redesign
required for implementation of the CCM [Chronic Care Model]
and linked educational strategies are achievable in resident
continuity practices….
Durable implementation of the CCM in resident practices
necessitates substantial commitment from local institutional,
clinical and academic leadership.81
…the modest improvement in clinical outcomes observed in
these practices in comparison with initiatives from single site
initiatives reported in the literature suggests that effective
care of patients with chronic illness may require prolonged
continuity of care that poses a challenge in many resident
practices, even in those committed to implementation of the
CCM.81
Including a telephone option as part of a review service for
people with asthma is a practical and cost-effective strategy
for enhancing access… These findings have direct clinical
implications and also policy implications for those setting
standards for the Quality and Outcomes Framework of the UK
GMS [General Medical Services] contract.18
Explanation
The authors should reflect on:
1. The implications of the success (or otherwise) of the implementation strategy, for research and practice.
2. The health benefits (or otherwise) of implementing the intervention.
Targets might include citizens, practitioners interested in the health intervention, researchers interested in the conceptual and
theoretical perspective, managers and clinical leaders interested in implementing the intervention and those interested in the
broader policy implications. A key point for consideration will be ‘sustainability’ (the extent to which the intervention can
continue to deliver its intended benefits over an extended period of time after any support has terminated) and how policy
could be modified to support ongoing implementation.
Scalability, generalisability, applicability and transferability of the implementation strategy may need to be discussed.
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CONCLUSIONS
The StaRI standards are registered with the EQUATOR
Network (http://www.equator-network.org) and the
checklist is available from this journal and BMJ.com. We
invite editors of journals publishing interventional
implementation studies to consider requiring submission
of a StaRI checklist, and authors reporting such studies
to adopt the checklist. We have presented the concepts
and sought feedback from delegates at workshops, con-
ference discussions and implementation project steering
groups; in general, the concepts seem to resonate with
colleagues. In the future, we would like to work with
authors as they apply the checklist to their papers, ‘road
testing’ the standards and enabling iterative
development.
We are particularly interested in whether the concept
of the dual strands (implementation strategy/interven-
tion) resonates with authors and readers of implementa-
tion studies. Is it practical to expect authors to consult
other methodological checklists for reporting design-
speciﬁc aspects of their study? We look forward to learn-
ing about innovative solutions to providing adequate
descriptions of context, implementation strategies and
interventions that accommodate the requirements of
journals, needs of authors as well as preferences of
readers.
Previously published statements have been instrumen-
tal in improving reporting standards,10 and our hope is
that StaRI will achieve a similar improvement in the
reporting of implementation strategies that will facilitate
translation of effective interventions into routine
practice.
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